EQUITY-BASED COMPENSATION EXPENSE - Schedule of Option Activity (Details) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Weighted Average Exercise Price
Weighted average remaining contractual term (in years)	5 years
Weighted average remaining contractual term, exercisable (in years)	6 years
Cost not yet recognized	$ 1,670,000
Fixed Shares
Options
Beginning balance (in shares)	7,337
Granted (in shares)	0
Forfeited (in shares)	0
Expired (in shares)	0
Ending balance (in shares)	7,337
Exercisable (in shares)	1,834
Weighted Average Exercise Price
Beginning balance (in USD per share)	$ 2.75
Granted (in USD per share)	0
Forfeited (in USD per share)	0
Expired (in USD per share)	0
Ending balance (in USD per share)	2.75
Exercisable (in USD per share)	$ 9.14
Aggregate intrinsic value for options outstanding	$ 0
Floating Shares
Options
Beginning balance (in shares)	2,267
Granted (in shares)	0
Forfeited (in shares)	0
Expired (in shares)	(31)
Ending balance (in shares)	2,236
Exercisable (in shares)	2,106
Weighted Average Exercise Price
Beginning balance (in USD per share)	$ 3.10
Granted (in USD per share)	0
Forfeited (in USD per share)	0
Expired (in USD per share)	2.55
Ending balance (in USD per share)	3.10
Exercisable (in USD per share)	$ 3.10
Options
Weighted Average Exercise Price
Vesting period (in years)	3 years
Equity-based compensation expense	$ 226,000	$ 282,000
Unrecognized compensation expense, period (in years)	2 years
Options | Minimum
Weighted Average Exercise Price
Expiration period (in years)	5 years
Weighted average remaining contractual term (in years)	6 years
Options | Maximum
Weighted Average Exercise Price
Expiration period (in years)	10 years
Weighted average remaining contractual term (in years)	7 years